What can we help you find?

Leading the way in transplantation

Filter results for:

NEW WEBINAR: Desensitisation Strategies on Tuesday, 1 March 2022 at 18:00 – 19:00 CET

Registration now open for the webinar ๐˜ฟ๐™š๐™จ๐™š๐™ฃ๐™จ๐™ž๐™ฉ๐™ž๐™จ๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™Ž๐™ฉ๐™ง๐™–๐™ฉ๐™š๐™œ๐™ž๐™š๐™จ on ๐—ง๐˜‚๐—ฒ๐˜€๐—ฑ๐—ฎ๐˜†, ๐Ÿญ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฎ๐˜ ๐Ÿญ๐Ÿด:๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ง!
With Prof. Nizam Mamode & Prof. Christophe Legendre

This activity is sponsored by Hansa Biopharma
Register now!

TLJ 2.0: New Papers Published

Following the TLJ 2.0 event last November, two important papers have been published in Transplant International focusing on the meetingโ€™s Workstream 4: Normothermic regional perfusion (NRP) in donation after circulatory death (DCD). One paper concerns a systematic review and meta-analyses of NRP in DCD donation, with the other focuses on a consensus statement on the

Technical & Logistical aspects of Performing Normothermic Regional Perfusion in Controlled Donation after Circulatory Death in Europe

A working group of European experts has summarised the current technique and logistical aspects as they are implemented in their countries and / or centres. From these discussions, and supported by literature, the TJL2.0 Work Stream has created a list of recommendations and minimal requirements any NRP programme should follow.ย  We ask your help to

The COVID-19 Vaccine Studies

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader

Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer – Open for comments until 06 April

This pre-print from TLJ 2.0 WS03 on โ€˜Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancerโ€™ is now open for comments on Transplant Live. Led by Umberto Maggiore, this paper will be submitted to Transplant International once feedback from our community has been collated. Login & provide your input today

Menu